IL92120A - Cyclosporin opthalmic compositions - Google Patents

Cyclosporin opthalmic compositions

Info

Publication number
IL92120A
IL92120A IL9212089A IL9212089A IL92120A IL 92120 A IL92120 A IL 92120A IL 9212089 A IL9212089 A IL 9212089A IL 9212089 A IL9212089 A IL 9212089A IL 92120 A IL92120 A IL 92120A
Authority
IL
Israel
Prior art keywords
composition according
component
composition
present
cyclosporin
Prior art date
Application number
IL9212089A
Other languages
English (en)
Other versions
IL92120A0 (en
Original Assignee
Sandoz A G Basle Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz A G Basle Switzerland filed Critical Sandoz A G Basle Switzerland
Publication of IL92120A0 publication Critical patent/IL92120A0/xx
Publication of IL92120A publication Critical patent/IL92120A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL9212089A 1988-10-26 1989-10-25 Cyclosporin opthalmic compositions IL92120A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (2)

Publication Number Publication Date
IL92120A0 IL92120A0 (en) 1990-07-12
IL92120A true IL92120A (en) 1994-02-27

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9212089A IL92120A (en) 1988-10-26 1989-10-25 Cyclosporin opthalmic compositions

Country Status (23)

Country Link
JP (1) JPH02164830A (fr)
KR (1) KR900005973A (fr)
AU (1) AU626928B2 (fr)
BE (1) BE1003578A4 (fr)
CA (1) CA2001502A1 (fr)
CH (1) CH679210A5 (fr)
DE (1) DE3935517A1 (fr)
DK (1) DK531289A (fr)
ES (1) ES2020032A6 (fr)
FI (1) FI895064A7 (fr)
FR (1) FR2638089A1 (fr)
GB (1) GB2224205B (fr)
GR (1) GR1000611B (fr)
HU (1) HU203046B (fr)
IL (1) IL92120A (fr)
LU (1) LU87613A1 (fr)
MY (1) MY106271A (fr)
NL (1) NL8902657A (fr)
NO (1) NO894266L (fr)
NZ (1) NZ231131A (fr)
PT (1) PT92120B (fr)
SE (1) SE8903583L (fr)
ZA (1) ZA898140B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CA2002147A1 (fr) * 1988-11-07 1990-05-07 Shuichi Morikawa Procede de production de fibres polyimides
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
JP3833248B2 (ja) 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
AU737053B2 (en) 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
JP2011502990A (ja) * 2007-11-05 2011-01-27 ボーシュ アンド ローム インコーポレイティド 薬物送達用ビヒクルとしての水非混和性物質
PL2437762T3 (pl) * 2009-06-05 2018-01-31 Allergan Inc Sztuczne łzy i ich zastosowania terapeutyczne
CA2967413C (fr) 2014-11-25 2023-08-15 Allergan, Inc. Compositions ophtalmiques contenant des huiles d'omega-3 stabilisees pardes antioxydants
DK3399962T3 (da) 2016-12-23 2020-09-07 Novaliq Gmbh Oftalmisk sammensætning til behandling af tør øjensygdom
WO2021044045A1 (fr) * 2019-09-06 2021-03-11 Novaliq Gmbh Composition ophtalmique pour le traitement de l'uvéite
EP4201398A1 (fr) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin de pour le traitement topique de maladies oculaires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
AU4371589A (en) 1990-05-03
ES2020032A6 (es) 1991-07-16
GB8924040D0 (en) 1989-12-13
SE8903583L (sv) 1990-04-27
CA2001502A1 (fr) 1990-04-26
HU895444D0 (en) 1990-01-28
KR900005973A (ko) 1990-05-07
LU87613A1 (fr) 1991-05-07
CH679210A5 (fr) 1992-01-15
FR2638089A1 (fr) 1990-04-27
IL92120A0 (en) 1990-07-12
FI895064A7 (fi) 1990-04-27
NO894266L (no) 1990-04-27
ZA898140B (en) 1991-06-26
NL8902657A (nl) 1990-05-16
SE8903583D0 (sv) 1989-10-26
DE3935517A1 (de) 1990-05-03
DK531289A (da) 1990-04-27
HU203046B (en) 1991-05-28
BE1003578A4 (fr) 1992-04-28
JPH02164830A (ja) 1990-06-25
FI895064A0 (fi) 1989-10-25
NO894266D0 (no) 1989-10-26
GB2224205A (en) 1990-05-02
DK531289D0 (da) 1989-10-25
GR890100690A (en) 1990-11-29
MY106271A (en) 1995-04-29
PT92120A (pt) 1990-04-30
GB2224205B (en) 1992-04-15
GR1000611B (el) 1992-08-31
NZ231131A (en) 1992-06-25
AU626928B2 (en) 1992-08-13
HUT52394A (en) 1990-07-28
PT92120B (pt) 1995-06-30

Similar Documents

Publication Publication Date Title
AU626928B2 (en) Cyclosporin opthalmic compositions
IT8948485A1 (it) Composizioni oftalmiche a base di una ciclosporina (caso 600-7089)
US5951971A (en) Ophthalmic compositions
Constad et al. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma
US6579901B2 (en) Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
EP4025235B1 (fr) Composition ophtalmique pour le traitement de l'uvéite
KR20070094600A (ko) 안질환 치료제
US11654140B2 (en) Treatment of ocular inflammatory diseases using laquinimod
CZ423797A3 (cs) Topické přípravky s imunosupresivy
Grehn et al. Thymoxamine: a miotic for intraocular use
Fallor et al. Ocular toxicity of experimental intravitreal vitamin E
HK1004520B (en) Ophthalmic compositions containing a cyclosporin

Legal Events

Date Code Title Description
RH Patent void